Illumina, Inc. (ILMN)

398.85 -0.76 (-0.19%) At close: 4:00PM EST

Illumina, Inc.

5200 Illumina Way
San Diego, CA 92122
United States
858 202 4500
http://www.illumina.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 7,800

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Francis A. deSouza	CEO, Pres & Director	N/A	N/A	1971
Mr. Sam A. Samad	Chief Financial Officer	626.7k	N/A	1970
Dr. Joydeep Goswami	Sr. VP of Corp. Devel. & Strategic Planning	384.38k	N/A	1971
Ms. Aimee L. Hoyt	Chief People Officer	864.07k	N/A	1972
Mr. Robert P. Ragusa	Chief Operations Officer	N/A	N/A	1960
Ms. Karen K. McGinnis CPA	VP & Chief Accounting Officer	N/A	N/A	1967
Dr. Alexander Aravanis M.D., Ph.D.	Chief Technology Officer	N/A	N/A	N/A
Mr. Steve Phillpott	Sr. VP & Chief Information Officer	N/A	N/A	N/A
Ms. Juliet Cunningham	VP of Investor Relations	N/A	N/A	N/A
Mr. Charles E. Dadswell	Gen. Counsel	N/A	N/A	1959

Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is headquartered in San Diego, California.

Corporate Governance

Illumina, Inc.’s ISS Governance QualityScore as of December 3, 2020 is 6. The pillar scores are Audit: 4; Board: 5; Shareholder Rights: 6; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.